AIM: To determine the significance of cholesteryl ester transfer protein (CETP) in lipoprotein abnormalities in chronic hepatitis C virus (HCV) infection. METHODS: We evaluated the significance of the serum concentration of CETP in 110 Japanese patients with chronic HCV infection. Fifty-five patients had active HCV infection, and HCV eradication had been achieved in 55. The role of CETP in serum lipoprotein abnormalities, specifically, in triglyceride (TG) concentrations in the four major classes of lipoproteins, was investigated using Pearson correlations in conjunction with multiple regression analysis and compared them between those with active HCV infection and those in whom eradication had been achieved. RESULTS: The serum CETP levels of patients with active HCV infection were significantly higher than those of patients in whom HCV eradication was achieved (mean ± SD, 2.84 ± 0.69 μg/mL vs 2.40 ± 1.00 μg/mL, P = 0.008). In multiple regression analysis, HCV infection status (active or eradicated) was an independent factor significantly associated with the serum CETP level. TG concentrations in low-density lipoprotein (mean ± SD, 36.25 ± 15.28 μg/mL vs 28.14 ± 9.94 μg/mL, P = 0.001) and high-density lipoprotein (HDL) (mean ± SD, 25.9 ± 7.34 μg/mL vs 17.17 ± 4.82 μg/mL, P < 0.001) were significantly higher in patients with active HCV infection than in those in whom HCV eradication was achieved. The CETP level was strongly correlated with HDL-TG in patients with active HCV infection (R = 0.557, P < 0.001), whereas CETP was not correlated with HDL-TG in patients in whom HCV eradication was achieved (R = -0.079, P = 0.56). CONCLUSION: Our results indicate that CETP plays a role in abnormalities of lipoprotein metabolism in patients with chronic HCV infection.
AIM: To determine the significance of cholesteryl ester transfer protein (CETP) in lipoprotein abnormalities in chronic hepatitis C virus (HCV) infection. METHODS: We evaluated the significance of the serum concentration of CETP in 110 Japanese patients with chronic HCV infection. Fifty-five patients had active HCV infection, and HCV eradication had been achieved in 55. The role of CETP in serum lipoprotein abnormalities, specifically, in triglyceride (TG) concentrations in the four major classes of lipoproteins, was investigated using Pearson correlations in conjunction with multiple regression analysis and compared them between those with active HCV infection and those in whom eradication had been achieved. RESULTS: The serum CETP levels of patients with active HCV infection were significantly higher than those of patients in whom HCV eradication was achieved (mean ± SD, 2.84 ± 0.69 μg/mL vs 2.40 ± 1.00 μg/mL, P = 0.008). In multiple regression analysis, HCV infection status (active or eradicated) was an independent factor significantly associated with the serum CETP level. TG concentrations in low-density lipoprotein (mean ± SD, 36.25 ± 15.28 μg/mL vs 28.14 ± 9.94 μg/mL, P = 0.001) and high-density lipoprotein (HDL) (mean ± SD, 25.9 ± 7.34 μg/mL vs 17.17 ± 4.82 μg/mL, P < 0.001) were significantly higher in patients with active HCV infection than in those in whom HCV eradication was achieved. The CETP level was strongly correlated with HDL-TG in patients with active HCV infection (R = 0.557, P < 0.001), whereas CETP was not correlated with HDL-TG in patients in whom HCV eradication was achieved (R = -0.079, P = 0.56). CONCLUSION: Our results indicate that CETP plays a role in abnormalities of lipoprotein metabolism in patients with chronic HCV infection.
Entities:
Keywords:
Case control study; Cholesteryl ester transfer protein; Hepatitis C virus; High-density lipoprotein triglyceride; Lipoprotein metabolism
Authors: Shirya Rashid; Allan Sniderman; Michelle Melone; Patrick E Brown; James D Otvos; Andrew Mente; Karleen Schulze; Matthew J McQueen; Sonia S Anand; Salim Yusuf Journal: Eur J Prev Cardiol Date: 2014-03-21 Impact factor: 7.804
Authors: Jean Michel Petit; Muriel Benichou; Laurence Duvillard; Valerie Jooste; Jean Baptiste Bour; Anne Minello; Bruno Verges; Jean Marcel Brun; Philippe Gambert; Patrick Hillon Journal: Am J Gastroenterol Date: 2003-05 Impact factor: 10.864
Authors: X C Jiang; P Moulin; E Quinet; I J Goldberg; L K Yacoub; L B Agellon; D Compton; R Schnitzer-Polokoff; A R Tall Journal: J Biol Chem Date: 1991-03-05 Impact factor: 5.157
Authors: Dicky L Tahapary; Karin de Ruiter; Farid Kurniawan; Yenny Djuardi; Yanan Wang; Siti M E Nurdin; Elisa Iskandar; Dominggus Minggu; Em Yunir; Bruno Guigas; Taniawati Supali; Patrick C N Rensen; Erliyani Sartono; Pradana Soewondo; Dante S Harbuwono; Johannes W A Smit; Maria Yazdanbakhsh Journal: Sci Rep Date: 2018-05-25 Impact factor: 4.379
Authors: David A Sheridan; Isaac Thom Shawa; E Louise Thomas; Daniel J Felmlee; Simon H Bridge; Dermot Neely; Jeremy F Cobbold; Elaine Holmes; Margaret F Bassendine; Simon D Taylor-Robinson Journal: Sci Rep Date: 2022-04-01 Impact factor: 4.379
Authors: Rafael Moreno-Luna; Mª Carmen Durán-Ruiz; Lucía Beltrán-Camacho; Sara Eslava-Alcón; Marta Rojas-Torres; Daniel Sánchez-Morillo; Mª Pilar Martinez-Nicolás; Victoria Martín-Bermejo; Inés García de la Torre; Esther Berrocoso; Juan Antonio Moreno Journal: Mol Med Date: 2022-04-09 Impact factor: 6.354